A detailed history of Lantz Financial LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Lantz Financial LLC holds 11,324 shares of JNJ stock, worth $1.74 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
11,324
Previous 10,101 12.11%
Holding current value
$1.74 Million
Previous $1.48 Million 24.32%
% of portfolio
0.52%
Previous 0.48%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$145.48 - $167.38 $177,922 - $204,705
1,223 Added 12.11%
11,324 $1.84 Million
Q2 2024

Jul 10, 2024

SELL
$144.38 - $157.78 $19,491 - $21,300
-135 Reduced 1.32%
10,101 $1.48 Million
Q1 2024

Apr 10, 2024

SELL
$155.22 - $162.74 $15,832 - $16,599
-102 Reduced 0.99%
10,236 $1.62 Million
Q4 2023

Jan 12, 2024

BUY
$145.6 - $158.88 $57,512 - $62,757
395 Added 3.97%
10,338 $1.62 Million
Q3 2023

Oct 20, 2023

BUY
$155.75 - $174.48 $6,697 - $7,502
43 Added 0.43%
9,943 $1.55 Million
Q2 2023

Jul 12, 2023

SELL
$154.35 - $166.11 $15,589 - $16,777
-101 Reduced 1.01%
9,900 $1.64 Million
Q1 2023

Apr 10, 2023

SELL
$151.05 - $180.26 $46,221 - $55,159
-306 Reduced 2.97%
10,001 $1.55 Million
Q4 2022

Jan 23, 2023

BUY
$160.2 - $179.79 $20,025 - $22,473
125 Added 1.23%
10,307 $0
Q3 2022

Oct 17, 2022

SELL
$161.33 - $179.52 $8,066 - $8,976
-50 Reduced 0.49%
10,182 $1.66 Million
Q2 2022

Jul 29, 2022

BUY
$168.19 - $186.01 $3,027 - $3,348
18 Added 0.18%
10,232 $1.82 Million
Q1 2022

May 05, 2022

BUY
$158.14 - $179.59 $5,534 - $6,285
35 Added 0.34%
10,214 $1.81 Million
Q4 2021

Jan 19, 2022

SELL
$155.93 - $173.01 $24,481 - $27,162
-157 Reduced 1.52%
10,179 $1.74 Million
Q3 2021

Oct 14, 2021

BUY
$161.5 - $179.47 $46,027 - $51,148
285 Added 2.84%
10,336 $1.67 Million
Q2 2021

Jul 16, 2021

BUY
$159.48 - $171.07 $23,922 - $25,660
150 Added 1.51%
10,051 $1.66 Million
Q1 2021

Apr 19, 2021

BUY
$153.07 - $170.48 $10,408 - $11,592
68 Added 0.69%
9,901 $1.63 Million
Q4 2020

Jan 19, 2021

BUY
$137.11 - $157.38 $56,352 - $64,683
411 Added 4.36%
9,833 $1.55 Million
Q3 2020

Oct 09, 2020

BUY
$140.38 - $153.83 $47,308 - $51,840
337 Added 3.71%
9,422 $1.4 Million
Q2 2020

Jul 22, 2020

BUY
$128.81 - $155.51 $55,388 - $66,869
430 Added 4.97%
9,085 $1.28 Million
Q1 2020

Apr 10, 2020

BUY
$111.14 - $153.99 $118,697 - $164,461
1,068 Added 14.08%
8,655 $1.14 Million
Q4 2019

Jan 17, 2020

SELL
$127.5 - $146.44 $28,177 - $32,363
-221 Reduced 2.83%
7,587 $1.11 Million
Q3 2019

Oct 18, 2019

SELL
$126.95 - $142.14 $29,198 - $32,692
-230 Reduced 2.86%
7,808 $1.03 Million
Q2 2019

Jul 15, 2019

SELL
$131.15 - $144.24 $101,116 - $111,209
-771 Reduced 8.75%
8,038 $1.13 Million
Q1 2019

Apr 22, 2019

BUY
$125.72 - $139.79 $1.11 Million - $1.23 Million
8,809 New
8,809 $1.23 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Lantz Financial LLC Portfolio

Follow Lantz Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantz Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantz Financial LLC with notifications on news.